You have access
Initial Safety and Outcomes of Miriplatin plus Low-dose Epirubicin for Transarterial Chemoembolisation of Hepatocellular Carcinoma
JIN IWAZAWA, NAOKO HASHIMOTO, SHOICHI OHUE and TAKASHI MITANI
Anticancer Research November 2012, 32 (11) 5039-5044;
